Developing an effective HIV vaccine: what do we need and when will we get there?

As part of EAVI2020's fourth annual meeting, this stakeholder webinar gave the public wider access to EAVI2020's research and scientists. The webinar was hosted at partner institution, CEA in Paris (France) on 24th October 2019.
First attempts to develop a vaccine against HIV started in the 1980s. Thirty years on and we still do not have a viable vaccine. Why has it been so difficult? What is needed to realise the goal of an effective vaccine? Is the development of a vaccine still a priority? Researchers from EAVI2020 – a €23 million EU-funded research initiative to accelerate the search for an effective HIV vaccine – tackled these challenging questions in a roundtable discussion.
Panellists:
Facilitator, Dr Roger Tatoud – International AIDS Society
Prof Robin Shattock – Imperial College London
Dr Roger le Grand – Commissariat à l’ énergie atomique et aux énergies alternatives (CEA)
Susan Barnett – Bill & Melinda Gates Foundation
Athina Kilpelainen – Vall d’Hebron Institut de Recerca

EAVI2020,HIV vaccine,AIDS,EU-funded,webinar,research innovation,Horizon2020,